Cargando…

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey

OBJECTIVE: As part of the Physicians’ Observational Work on Patient Education According to their Vascular Risk (POWER) survey, we used Framingham methodology to examine the effect of an eprosartan-based regimen on total coronary heart disease (CHD) risk in diabetic patients recruited in Canada. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrella, Robert J, Gill, Dawn P, Berrou, Jean-Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376186/ https://www.ncbi.nlm.nih.gov/pubmed/25848310 http://dx.doi.org/10.2147/DMSO.S79221

Ejemplares similares

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey
por: Petrella, Robert J, et al.
Publicado: (2014)

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
por: Goudev, Assen, et al.
Publicado: (2012)

Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study
por: Radaideh, Ghazi Ahmad, et al.
Publicado: (2011)

Effects of Eprosartan on Target Organ Protection
por: de la Sierra, Alejandro
Publicado: (2006)

Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury
por: Weymann, Alexander, et al.
Publicado: (2014)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Lichenoid drug eruption due to eprosartan/hydrochlorothiacide
por: Ruiz-Villaverde, Ricardo, et al.
Publicado: (2011)

Effects of Eprosartan on Serum Metabolic Parameters in Patients with Essential Hypertension
por: Rizos, Evangelos C, et al.
Publicado: (2007)

Effect of Antihypertensive Therapy on SCORE-Estimated Total Cardiovascular Risk: Results from an Open-Label, Multinational Investigation—The POWER Survey
por: De Backer, Guy, et al.
Publicado: (2013)

A novel approach to treatment of hypertension in diabetic patients – a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 – rationale and design [ISRCTN55725285]
por: Pater, Cornel, et al.
Publicado: (2004)

Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
por: Blankestijn, P. J, et al.
Publicado: (2008)

Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction
por: Voors, Adriaan A., et al.
Publicado: (2010)

Simultaneous analysis of eprosartan and hydrochlorothiazide in tablets by high-performance liquid chromatography
por: Patel, Harsha U., et al.
Publicado: (2011)

Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate
por: Ahad, Abdul, et al.
Publicado: (2017)

Integrated genetic and epigenetic prediction of coronary heart disease in the Framingham Heart Study
por: Dogan, Meeshanthini V., et al.
Publicado: (2018)

Weak Prediction Power of the Framingham Risk Score for Coronary Artery Disease in Nonagenarians
por: Yayan, Josef
Publicado: (2014)

Formulation and characterization of eprosartan mesylate and β-cyclodextrin inclusion complex prepared by microwave technology
por: Ahad, Abdul, et al.
Publicado: (2022)

The Canadian survey of health, lifestyle and ageing with multiple sclerosis: methodology and initial results
por: Ploughman, Michelle, et al.
Publicado: (2014)

ASSOCIATION OF COGNITION AND SMARTPHONE SURVEY ATTRIBUTES IN THE ELECTRONIC FRAMINGHAM HEART STUDY
por: Pathiravasan, Chathurangi, et al.
Publicado: (2022)

Obesity Phenotype and Coronary Heart Disease Risk as Estimated by the Framingham Risk Score
por: Park, Yong Soon, et al.
Publicado: (2012)

Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults
por: Rodondi, Nicolas, et al.
Publicado: (2012)

Consistency of linkage results across exams and methods in the Framingham Heart Study
por: Atwood, Larry D, et al.
Publicado: (2003)

Development and Validation of a UV Spectrophotometric Method for the Simultaneous Estimation of Eprosartan Mesylate and Hydrochlorothiazide in Bulk and Formulations
por: Anandakumar, K., et al.
Publicado: (2011)

Digital Connectedness in the Framingham Heart Study
por: Fox, Caroline S., et al.
Publicado: (2016)

Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort
por: Yan, Yu, et al.
Publicado: (2009)

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
por: Joshi, Parag H., et al.
Publicado: (2016)

Adding multiple risk factors improves Framingham coronary heart disease risk scores
por: Hu, Guizhou, et al.
Publicado: (2014)

Framingham Heart Study genome-wide association: results for pulmonary function measures
por: Wilk, Jemma B, et al.
Publicado: (2007)

Power of linkage analysis using traits generated from simulated longitudinal data of the Framingham Heart Study
por: Wang, Dai, et al.
Publicado: (2003)

Prediction of Risk Factors for Coronary Heart Disease Using Framingham Risk Score in Korean Men
por: Ryoo, Jae-Hong, et al.
Publicado: (2012)

A longitudinal analysis of the risk factors for diabetes and coronary heart disease in the Framingham Offspring Study
por: Bhargava, Alok
Publicado: (2003)

Factors Related to Coronary Heart Disease Risk Among Men: Validation of the Framingham Risk Score
por: Gander, Jennifer, et al.
Publicado: (2014)

Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study
por: Hoffmann, Udo, et al.
Publicado: (2016)

Pedigree and genotype errors in the Framingham Heart Study
por: Brush, Gerry, et al.
Publicado: (2003)

Transmission-ratio distortion in the Framingham Heart Study
por: Paterson, Andrew D, et al.
Publicado: (2009)

Copy number variation in the Framingham Heart Study
por: Shtir, Corina, et al.
Publicado: (2009)

Trends in Diabetes Incidence: The Framingham Heart Study
por: Abraham, Tobin M., et al.
Publicado: (2015)

Inverse association between cancer and Alzheimer’s disease: results from the Framingham Heart Study
por: Driver, Jane A, et al.
Publicado: (2012)

Metabolic Syndrome versus Framingham Risk Score for Association of Self-Reported Coronary Heart Disease: The 2005 Korean Health and Nutrition Examination Survey
por: Kang, Hye Mi, et al.
Publicado: (2012)

Patterns of Abdominal Fat Distribution: The Framingham Heart Study
por: Pou, Karla M., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i8favkg5cctacj6vbrhiblku77